Metformin action in human hepatocytes: coactivation of atypical protein kinase C alters 5'-AMP-activated protein kinase effects on lipogenic and gluconeogenic enzyme expression.
about
Atypical PKC: a target for treating insulin-resistant disorders of obesity, the metabolic syndrome and type 2 diabetes mellitus.PKCλ haploinsufficiency prevents diabetes by a mechanism involving alterations in hepatic enzymes.Akt-dependent phosphorylation of hepatic FoxO1 is compartmentalized on a WD40/ProF scaffold and is selectively inhibited by aPKC in early phases of diet-induced obesity.Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.Higher protein kinase C ζ in fatty rat liver and its effect on insulin actions in primary hepatocytesHepatic Atypical Protein Kinase C: An Inherited Survival-Longevity Gene that Now Fuels Insulin-Resistant Syndromes of Obesity, the Metabolic Syndrome and Type 2 Diabetes MellitusBMI-related progression of atypical PKC-dependent aberrations in insulin signaling through IRS-1, Akt, FoxO1 and PGC-1α in livers of obese and type 2 diabetic humansCompensation for PKMζ in long-term potentiation and spatial long-term memory in mutant mice.Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis.5-Aminoimidazole-4-carboxyamide-1-β-D-ribofranoside stimulates the rat enhancer of split- and hairy-related protein-2 gene via atypical protein kinase C lambda
P2860
Q30366716-73CDBE20-2383-41BB-8E5B-D11B78D10AA7Q33821585-04419D6F-F15C-4F84-BCDF-6760417605E0Q33959753-0145DE0B-8934-437D-990D-EB438C4E7D72Q34757485-BEC6B2EB-C54F-41FF-80F4-7EF413E50F62Q35231302-FFB96240-2FE5-4147-8016-15796917D4DCQ35667136-612D7031-3FF3-47F2-8AEB-E8206A9652D1Q36077931-8D737039-913B-4F47-BAB0-C74ED6BE3407Q36908820-DDB209CA-A194-46C8-9858-F1DBE7A24B48Q42378305-666907F8-D4AC-4924-8C98-923275E78257Q42751388-F74E1B29-607A-4167-93A9-A3CC7EE82B35
P2860
Metformin action in human hepatocytes: coactivation of atypical protein kinase C alters 5'-AMP-activated protein kinase effects on lipogenic and gluconeogenic enzyme expression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metformin action in human hepa ...... uconeogenic enzyme expression.
@en
Metformin action in human hepa ...... uconeogenic enzyme expression.
@nl
type
label
Metformin action in human hepa ...... uconeogenic enzyme expression.
@en
Metformin action in human hepa ...... uconeogenic enzyme expression.
@nl
prefLabel
Metformin action in human hepa ...... uconeogenic enzyme expression.
@en
Metformin action in human hepa ...... uconeogenic enzyme expression.
@nl
P2093
P2860
P1433
P1476
Metformin action in human hepa ...... uconeogenic enzyme expression.
@en
P2093
Mini P Sajan
Robert A Ivey
Robert V Farese
P2860
P2888
P304
P356
10.1007/S00125-013-3010-1
P577
2013-08-10T00:00:00Z